APOE and Alzheimer disease: SnRNA‐seq indicated that Apoe4–CC mutation increased the abundance of disease‐protective cell population while reducing the abundance of disease‐associated cell population in a gene‐dose‐dependent manner, thereby preventing Apoe4‐induced AD pathology (Figure 3).